Moreover, MEX3D is frequently deleted in various human cancers [46], participates in modulating the effectiveness of chemotherapy in AML (acute myeloid leukaemia) [47], and is overexpressed in androgen-independent prostate cancer [48]. Here, MEX3D is linked to cancer.